RiverPark Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Buy
6,216
+521
+9% +$21K 0.13% 80
2026
Q1
$189K Buy
5,695
+174
+3% +$5.66K 0.07% 89
2025
Q4
$181K Buy
+5,521
New +$136K 0.05% 96

Other funds holding AXGN

RiverPark Advisors's AXGN Position: Q2 2026 in Review

RiverPark Advisors increased its Axogen (AXGN) stake by 9.1% in Q2 2026, buying an estimated $21K and bringing the position to 6,216 shares worth $287K. The position accounts for 0.13% of the portfolio, ranked #80.

RiverPark Advisors first reported a position in AXGN in Q4 2025 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • RiverPark Advisors held 6,216 shares of Axogen worth $287K as of Q2 2026.
  • RiverPark Advisors bought 521 Axogen shares in Q2 2026, an estimated $21K.
  • Axogen made up 0.13% of RiverPark Advisors's portfolio in Q2 2026, its #80 holding.
  • RiverPark Advisors first reported a position in Axogen in Q4 2025 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on RiverPark Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.